Immune tolerance induced by adoptive transfer of dendritic cells in an insulin-dependent diabetes mellitus murine model

Acta Pharmacologica Sinica

Volumn 28, Issue 1, 2007, Pages 98-104

  Zhang, Cheng Liang ^a   Zou, Xiao Lei ^a   Peng, Jia Bei ^a   Xiang, Ming ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Dendritic cells; Immune tolerance; Insulin dependent diabetes mellitus; Regulatory T cells; Streptozotocin

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; GLUCOSE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CELL PROTECTION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTER; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPOIESIS; MALE; MOUSE; NONHUMAN; PANCREAS; PANCREAS ISLET; PHENOTYPE; STREPTOZOCIN DIABETES; TH1 CELL; TH2 CELL;

EID: 33845998153     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00467.x     Document Type: Article

References (24)

1. Yu LY, Lin B, Zhang ZL, Guo LH. Direct transfer of A20 gene into pa ncreas protected mice from streptozotocin-induced diabetes. Acta Pharmacol Sin 2004; 25: 721-6.
2. Raz I, Eldor R, Naparstek Y. Immune modulation for prevention of type 1 diabetes mellitus. Trends Biotechnol 2005; 23: 128-34.
3. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-52.
4. Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003; 18: 605-17.
5. Xiao BG, Huang YM, Yang JS, Xu LY, Link H. Bone marrow-derived dendritic cells from experimental allergic encephalomyelitis induce immune tolerance to EAE in Lewis rats. Clin Exp Immunol 2001; 125: 300-9.
6. Clare-Salzler MJ, Brooks J, Chai A, Van Herle K, Anderson C. Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J Clin Invest 1992; 90: 741-8.
7. Holstad M, Sandler S. A transcriptional inhibitor of TNF-γ prevents diabetes induced by multiple low-dose streptozotocin injections in mice. J Autoimmun 2001; 16: 441-7.
8. Pechhold K, Patterson NB, Blum C, Fleischacker CL, Boehm BO, Harlan DM. Low dose streptozotocin-induced diabetes in rat insulin promoter-mCD80- transgenic mice is T cell autoantigen-specific and CD28 dependent. J Immunol 2001; 166: 253-9.
9. Yang Z, Chen M, Fialkow LB, Ellet JD, Wu R, Nadler JL. The novel anti-inflammatory compound, lisofylline, prevents diabetes in multiple low-dose streptozotocin-treated mice. Pancreas 2003; 26: e99-104.
10. Mensah-Brown EP, Stosic Grujicic S, Maksimovic D, Jasima A, Shahin A, Lukic ML. Downregulation of apoptosis in the target tissue prevents low-dose streptozotocin-induced autoimmune diabetes. Mol Immunol 2002; 38: 941-6.
11. Liu B, Zhang ZL, Yu LY, Guo LH. CMV-hFasL transgenic mice are sensitive to low doses of streptozotocin-induced type I diabetes mellitus. Acta Pharmacol Sin 2003; 24: 1199-204.
12. Morel PA, Vasquez AC, Feili-Hariri M. Immunobiology of DC in NOD mice. J Leukoc Biol 1999; 66: 276-80.
13. Hirano A, Fraser MO, Jordan ML, Takayama T, Lu L, Thomson AW. Graft hyporeactivity induced by donor-derived dendritic cell progenitors. Transplant Proc 2000; 32: 260-4.
14. Machen J, Harnaha J, Lakomy R, Styche A, Trucco M, Giannoukakis N. Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells. J Immunol 2004; 173: 4331-41.
15. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. Regulatory T cells induced by 1 alpha, 25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001; 167: 1945-53.
16. Lechler R, Ng WF, Steinman RM. Dendritic cells in transplantation-friend or foe? Immunity 2001; 14: 357-68.
17. Canning MO, Grotenhuis K, de Wit H, Ruwhof C, Drexhage HA. 1-alpha, 25-Dihydroxyvitamin D3 (1, 25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol 2001; 145: 351-7.
18. Adorini L, Penna G, Giarratana N, Uskokovic M. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J Cell Biochem 2003; 88: 227-33.
19. Shevach EM. Regulatory T cells in autoimmunity. Annu Rev Immunol 2000; 18: 423-49.
20. Serreze DV, Leiter EH. Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies. J Immunol 1988; 140: 3801-7.
21. + immunoregulatory T cells that control autoimmune diabetes. Immunity 2000; 12: 431-40.
22. Xiang M, Zhang CL, Zou XL, Cai XH, Peng JB. Roles of dendritic cells and regulatory cells in autoantigen-induced murine immune tolerance model. World Chin J Digestol 2006; 14: 687-92.
23. Hoyne GF, Dallman MJ, Lamb JR. T-cell regulation of peripheral tolerance and immunity: the potential role for Notch signalling. Immunology 2000; 100: 281-8.
24. Stassen M, Schmitt E, Jonuleit H. Human CD4+ CD25+ regulatory T cells and infectious tolerance. Transplantation 2004; 77: s23-25.